Paul Disilverstro

发表

A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.

W. Richards, D. Mutch, A. Secord, 2019, Journal of Clinical Oncology.